<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01464398</url>
  </required_header>
  <id_info>
    <org_study_id>34145EP</org_study_id>
    <secondary_id>K23AT006340</secondary_id>
    <nct_id>NCT01464398</nct_id>
  </id_info>
  <brief_title>Stress Reduction for Overweight or Obese Women Either With Polycystic Ovary Syndrome (PCOS) or Without PCOS (Non-PCOS)</brief_title>
  <official_title>Stress Reduction for PCOS and Non-PCOS Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of stress reduction on glucose, blood
      pressure, quality of life and overall health and well-being in overweight or obese women,
      either with Polycystic Ovary Syndrome (PCOS) or without PCOS (non-PCOS). Stress reduction
      treatment sessions will include one or more of the following activities: breathing exercises,
      meditation, stretching exercises or health education activities.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in Toronto Mindfulness Scale at 8 weeks</measure>
    <time_frame>baseline and 8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Toronto Mindfulness Scale at 16 weeks</measure>
    <time_frame>baseline and 16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Hemoglobin A1c at 8 weeks</measure>
    <time_frame>baseline and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Hemoglobin A1c at 16 weeks</measure>
    <time_frame>baseline and 16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Mean Arterial Pressure at 8 weeks</measure>
    <time_frame>baseline and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Mean Arterial Pressure at 16 weeks</measure>
    <time_frame>baseline and 16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in SF-36 at 8 weeks</measure>
    <time_frame>baseline and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in SF-36 at 16 weeks</measure>
    <time_frame>baseline and 16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Brief Symptom Inventory-18 at 8 weeks</measure>
    <time_frame>baseline and 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Brief Symptom Inventory-18 at 16 weeks</measure>
    <time_frame>baseline and 16 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <condition>Overweight</condition>
  <condition>Obesity</condition>
  <condition>Stress, Physiological</condition>
  <condition>Stress, Psychological</condition>
  <arm_group>
    <arm_group_label>Stress reduction</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mindfulness-based stress reduction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stress reduction with Health education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>General stress management and health education</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stress reduction</intervention_name>
    <description>8 weekly sessions</description>
    <arm_group_label>Stress reduction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stress reduction with Health education</intervention_name>
    <description>8 weekly sessions</description>
    <arm_group_label>Stress reduction with Health education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women, age 18 years or older

          2. Body mass index (BMI) â‰¥ 25 kg/m2 (overweight or obese)

        Exclusion criteria:

          1. Current pregnancy

          2. Secondary causes of hyperandrogenemia, such as known or suspected androgen secreting
             tumors, Cushing's syndrome, or hyperprolactinemia (prolactin &gt;30)

          3. Untreated hypothyroidism or hyperthyroidism (defined as TSH &lt;0.2 or &gt;5.5 mIU/mL)

          4. Severe active neuropsychological disorder such as psychosis or suicidal ideation

          5. Severe untreated depression or anxiety. Women with severe depression or anxiety will
             be allowed to participate if they are under the care of a mental health specialist as
             long as they have permission to do so from their mental health specialist and will
             continue to follow-up with their mental health specialist during the study.

          6. History of an inpatient admission for psychiatric disorder within the past two years

          7. Active alcohol or drug abuse

          8. Inability to read, speak or write English

          9. Inability to commit to the intervention and follow-up

         10. Current enrollment in a stress reduction program

         11. Mindfulness practice within the past 6 months (regular formal practice at least once a
             week)

         12. Current enrollment in other investigative studies

         13. Type 1 diabetes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nazia Raja-Khan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennsylvania State University College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Penn State College of Medicine, Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2011</study_first_submitted>
  <study_first_submitted_qc>November 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2011</study_first_posted>
  <last_update_submitted>May 13, 2015</last_update_submitted>
  <last_update_submitted_qc>May 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Nazia Raja-Khan</investigator_full_name>
    <investigator_title>M.D., Assistant Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism</investigator_title>
  </responsible_party>
  <keyword>Polycystic Ovary Syndrome</keyword>
  <keyword>stress</keyword>
  <keyword>mindfulness</keyword>
  <keyword>meditation</keyword>
  <keyword>health education</keyword>
  <keyword>women</keyword>
  <keyword>overweight</keyword>
  <keyword>obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Stress, Psychological</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

